{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:19:09Z","timestamp":1778257149566,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010035","name":"Sheffield Hallam University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13643-019-1030-8","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T19:02:31Z","timestamp":1558033351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-4012","authenticated-orcid":false,"given":"Amie","family":"Woodward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markos","family":"Klonizakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Lahart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouska","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Broom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1030_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4614-8394-6_8","volume-title":"Polycystic ovary syndrome: current and emerging concepts","author":"M Aubuchon","year":"2014","unstructured":"Aubuchon M, Bickhaus J, Gonzalez F. Obesity, metabolic dysfunction, and inflammation in polycystic ovary syndrome. In: Pal L, editor. Polycystic ovary syndrome: current and emerging concepts. New York: Springer; 2014. p. 117\u201344."},{"issue":"1","key":"1030_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1385\/ENDO:29:1:109","volume":"29","author":"G Bray","year":"2006","unstructured":"Bray G, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29(1):107\u201317.","journal-title":"Endocrine."},{"issue":"3","key":"1030_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","volume":"53","author":"J Kim","year":"2013","unstructured":"Kim J, Choi Y. Dyslipidemia in women with polycystic ovary syndrome. Obstet Gynecol Sci. 2013;53(3):137\u201342.","journal-title":"Obstet Gynecol Sci"},{"key":"1030_CR6","doi-asserted-by":"crossref","unstructured":"Sattar N. Vascular and metabolic issues in PCOS. In: Greer I, Ginsbery J, Forbes C, editors. Women's vascular health. Boca Raton: Taylor & Francies Group; 2006. p. 265\u201379.","DOI":"10.1201\/b13359-23"},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/9781444347319.ch16","volume-title":"The Metabolic Syndrome","author":"Naveed Sattar","year":"2011","unstructured":"Sattar N. Polycystic ovary syndrome. In: Byrne C, Wild S, editors. The metabolic syndrome. Chichester: Blackwell Publishing Ltd; 2011. p. 278\u201398."},{"issue":"9","key":"1030_CR8","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2337\/db11-1360","volume":"61","author":"A Gamberini","year":"2012","unstructured":"Gamberini A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, Pasquali R. Polycystic ovary syndrome is a risk factor for type 2 diabetes. Diabetes. 2012;61(9):2369\u201374.","journal-title":"Diabetes."},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26:883\u201396.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"1030_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","volume":"97","author":"AJ Duleba","year":"2012","unstructured":"Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012;97(1):7\u201312.","journal-title":"Fertil Steril"},{"issue":"3","key":"1030_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/07435800.2015.1135442","volume":"41","author":"M Calan","year":"2016","unstructured":"Calan M, Kume T, Yilmaz O, Arkan T, Kocabas GU, Dokuzlar O, et al. A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome. Endocr Res. 2016;41(3):261\u20139.","journal-title":"Endocr Res"},{"issue":"1","key":"1030_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2004-0628","volume":"90","author":"F Orio","year":"2005","unstructured":"Orio F, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanov\u00e0 L, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(1):2\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1030_CR13","doi-asserted-by":"publisher","unstructured":"Calan M, Guler A, Unal Kocabas G, Alarslan P, Bicer M, Imamoglu C, et al. The anti-inflammatory protein kallistatin is associated with carotid intima media thickness in women with polycystic ovary syndrome. Minerva Endocrinol. 2017. \n                    https:\/\/doi.org\/10.23736\/S0391-1977.17.02586-X\n                    \n                  .","DOI":"10.23736\/S0391-1977.17.02586-X"},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biochi.2014.10.028","volume":"124","author":"JD Covington","year":"2016","unstructured":"Covington JD, Tam CS, Pasarica M, Redman LM. Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise. Biochimie. 2016;124:27\u201333.","journal-title":"Biochimie."},{"issue":"8","key":"1030_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","volume":"39","author":"Y \u00c7ak\u0131ro\u011flu","year":"2016","unstructured":"\u00c7ak\u0131ro\u011flu Y, Vural F, Vural B. The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocrinol Investig. 2016;39(8):899\u2013907.","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"1030_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/humupd\/dmr046","volume":"18","author":"ML Meyer","year":"2012","unstructured":"Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(2):112\u201326.","journal-title":"Hum Reprod Update"},{"key":"1030_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-4614-8394-6_9","volume-title":"Polycystic ovary syndrome: current and emerging concepts","author":"A Krystock","year":"2014","unstructured":"Krystock A. Role of lifestyle and diet in the management of polycysitc ovarian syndrome. In: Pal L, editor. Polycystic ovary syndrome: current and emerging concepts. New York: Springer; 2014. p. 147\u201364."},{"issue":"2","key":"1030_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/humupd\/dmq045","volume":"17","author":"CL Harrison","year":"2011","unstructured":"Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011;17(2):171\u201383.","journal-title":"Hum Reprod Update"},{"issue":"7414","key":"1030_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ."},{"key":"1030_CR20","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley & Sons; 2011."},{"key":"1030_CR21","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014."},{"issue":"10","key":"1030_CR22","doi-asserted-by":"publisher","first-page":"e108263","DOI":"10.1371\/journal.pone.0108263","volume":"9","author":"Elisabeth Lerchbaum","year":"2014","unstructured":"Lerchbaum E, Schwetz V, Rabe T, Giuliani A, Obermayer-Pietsch B. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype. PLoS One. 2014. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0108263\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"7454","key":"1030_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490\u20134.","journal-title":"BMJ."},{"issue":"6","key":"1030_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/s-0032-1328878","volume":"30","author":"R Legro","year":"2012","unstructured":"Legro R. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 2012;30(6):496\u2013506.","journal-title":"Semin Reprod Med"},{"key":"1030_CR25","first-page":"297","volume-title":"Polycystic ovary syndrome","author":"S Ayup","year":"2007","unstructured":"Ayup S, Vega P, Halliscak R, Montezco M, Resendiz V, Gonzalez J, et al. Insulin-sensitizing drugs in the treatment of women with PCOS - the promise of metformin. In: Allahbadia G, Agrawal R, editors. Polycystic ovary syndrome. 3rd ed. Kent: Anshan Ltd; 2007. p. 297\u2013305.","edition":"3"},{"issue":"3","key":"1030_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2337\/dc06-0618","volume":"30","author":"C Meyer","year":"2007","unstructured":"Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care. 2007;30(3):471\u20138.","journal-title":"Diabetes Care"},{"key":"1030_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/762615","volume":"2013","author":"J Johansson","year":"2013","unstructured":"Johansson J, Stener-Victorin E. Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med. 2013;2013:1\u201316.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1030_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bpobgyn.2016.03.009","volume":"37","author":"D Dewailly","year":"2016","unstructured":"Dewailly D. Diagnostic criteria for PCOS: is there a need for a rethink? Best Pract Res Clin Obstet Gynaecol. 2016;37:5\u201311.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1030_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphys.2016.00124","volume":"7","author":"S El Hayek","year":"2016","unstructured":"El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: an updated overview. Front Physiol. 2016;7:124.","journal-title":"Front Physiol"},{"issue":"6","key":"1030_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/09513590.2012.760195","volume":"29","author":"K Ebejer","year":"2013","unstructured":"Ebejer K, Calleja-Agius J. The role of cytokines in polycystic ovarian syndrome. Gynecol Endocrinol. 2013;29(6):536\u201340.","journal-title":"Gynecol Endocrinol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-019-1030-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:28:22Z","timestamp":1589498902000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-019-1030-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1186\/s13643-019-1030-8","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"116"}}